Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT06180746
Active, not recruiting Observational

Study of the Conditions of the Effects of Health Mediation on Underserved Population

NCT06180746 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Bordeaux
Phase
Observational
Started
2024-01-01
Last updated
2026-06-23

Condition(s) studied

Mediation

Investigational drug(s) / intervention(s)

Knowledge mobilization to facilitate the structuring of health mediation

Knowledge mobilization to facilitate the structuring of health mediation: The ECEMSo intervention involves knowledge mobilization to facilitate the structuring of health mediation throughout French territory, and the development of a co-designed effective action plan to facilitate cancer screening uptake by people living in informal housing. The action plan will, consider territorial specificities at the regional level. The ECEMSo project team will organize a seminar and three workshops. The aim of the seminar and workshops is to mobilize knowledge to facilitate i) the structuring of health mediation in the regions, and ii) the development of an action plan with health mediators and other stakeholders to foster organized cancer screenings uptake by underserved people. This action plan must match with the needs of people living in informal housing, and must be coordinated, suitable and feasible to implement, in terms of knowledge about people living in informal housing specificities and specific local collaborations

Study summary

The investigators are conducting a longitudinal mixed-method intervention study with a multi-center, multi-case explanatory sequential design. The ECEMSo study aims to identify the impact of health mediation on fostering healthcare utilization, in particular organized cancer screening uptake, by underserved populations living in informal housing in France.

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
Accepted
People living in informal housing Inclusion criteria: * Living on the streets, in a shanty house, squat or caravan * Living in an area covered by one of care structures participating in the ECEMSo study * Being over 18 years old * Being able to understand the detailed information provided about the ECEMso study Exclusion criteria: * Suffering from cognitive and/or psychiatric disorders * Being under guardianship or curatorship Health mediators, heal workers, socials workers Inclusion criteria: * Being a health mediator, a health worker or a social worker belonging to one of the study's participation care structures * Providing support to people living in informal housing Exclusion criteria: No Stakeholder: Inclusion criteria: Being an actor concerned or involved with the issues and needs of people living in informal housing Exclusion criteria: No

Primary outcome measure(s)

  • Impact of health mediation on healthcare utilization in people living in informal housing (PLIH) in France — At six months follow-up
    The difference in healthcare utilization by PLIH between groups 2 and group 3
  • Impact of the intervention on people living in informal housing (PLIH) uptake of organized cancer screening — At six months follow-up
    The difference in organized cancer screening uptake (breast cancer, colorectal cancer, cervical cancer) between PLIH in group 1 and PLIH in group 2
  • Health mediation conditions required to foster utilization of healthcare services among people living in informal housing (PLIH) in France — At six months follow-up
    The difference in organized cancer screening uptake (at 2 years since diagnosis for breast cancer and colorectal cancer, at 3 years since diagnosis for cervical cancer) between PLIH in group 1 and people living in informal housing in group 3

Trial sites (1)

FacilityCityRegionStatus
CHU de Bordeaux Bordeaux France

More University Hospital, Bordeaux trials in France

TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA Recruiting
3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME) Recruiting
Post-Stroke Secondary Prevention With Digital Monitoring Recruiting
Test and Optimization of New Specific MRI Sequences on an Imager Dedicated to Research Recruiting
Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06180746 on ClinicalTrials.gov ↗ ← All trials in France